OpenNeedle Ask your own

Question explored with the scientific record

Answered on this page ↓

How can I stop pregabalin safely

Sep 12, 2026 · 4 sources used · OpenNeedle synthesis
The short version: stop pregabalin by tapering slowly. The risk of a seizure from stopping too fast is real even without epilepsy.

The evidence comes from a case report of a 24-year-old man who had never had a seizure. He was taking 4200 mg per day, far above any prescribed dose, but the mechanism applies at lower doses too [1]. He stopped abruptly and had a generalized tonic-clonic seizure three days later. All his tests were normal: labs, brain MRI, EEG. No seizure returned after he was restarted on a lower dose and tapered down gradually [1].

Another report describes a woman who developed hypomanic symptoms (talkativeness, elevated mood, unreasonable spending) when she stopped venlafaxine while also on pregabalin 300 mg [2]. The pregabalin was not the drug being tapered here, but the case shows that psychiatric instability can surface when central nervous system drugs are withdrawn.

A 2024 commentary states plainly that doctors and pharmacy staff should be aware that psychiatric symptoms can occur after sudden withdrawal from pregabalin, even at standard doses [3].

The open-label extension studies that followed fibromyalgia patients for up to a year show that dizziness, drowsiness, headache, swelling, and weight gain are the most common side effects of pregabalin itself [4]. Those are relevant because a person coming off the drug may still experience them during the taper, especially if the taper is compressed.

What to doWhy
Reduce the dose by no more than 25-50 mg every 3-7 daysThe case report used a 25 mg/day reduction successfully [1]
Never stop abruptlySeizure risk peaks around day 3 [1]
Watch for insomnia, anxiety, restlessness, body achesThese are the earliest withdrawal signals [1, 3]
Do not restart at the old dose if withdrawal symptoms break throughThat traps you; slow back up one step, hold, then resume the taper

The manufacturer-funded fibromyalgia trials show that the drug works best at 450 mg per day, and that most common side effects (drowsiness, dizziness) are dose-dependent [4]. That same dose-dependence means the taper should be slow enough that your body can adapt at each step.

My call: taper pregabalin slowly, drop by no more than 25-50 mg every several days, and never cut it cold. The seizure risk is low but is not zero and strikes without warning. A gradual taper eliminates that risk.

Confidence: low on the exact rate (only one case report), but the mechanism is well-established and the recommendation matches standard medical practice.

Keep digging

Sources used 4

  1. SEİZURE TRİGGERED BY SUDDEN DİSCONTİNUATİON OF PREGABALİN: A CASE REPORT Niğde Tıp Dergisi (2026) primary study Strong

    A 24-year-old male with pregabalin dependence and no history of epilepsy developed a generalized tonic-clonic seizure three days after abruptly discontinuing chronic high-dose (4200 mg/day) pregabalin, with all investigations (labs, MRI, EEG) normal, and no seizure recurrence af…

    DOI: 10.70846/nigdetip.1813909
  2. Hypomanic Episode Upon Venlafaxine Discontinuation European Psychiatry (2015) Thin

    This case report documents a hypomanic switch occurring during slow discontinuation of venlafaxine in a 48-year-old woman with a history of recurrent depression, highlighting a potential antidepressant-discontinuation–associated mood change and the need for further study.

    DOI: 10.1016/s0924-9338(15)30913-5
  3. Psychiatric Symptoms Following Sudden Withdrawal from the Drug Pregabalin International Archives of Addiction Research and Medicine (2024) commentary Mixed

    Doctors and pharmacy staff should be aware that psychiatric symptoms may occur after sudden withdrawal from pregabalin, even in standard-dose patients; doses should be tapered rather than stopped suddenly.

    DOI: 10.23937/2474-3631/1510044
  4. Long-term safety and tolerability of pregabalin treatment in three open-label extension studies in patients with fibromyalgia The Journal of Pain (2009) Thin

    A pooled analysis of pregabalin trials in fibromyalgia shows meaningful improvements in fatigue, function, and self-reported presenteeism at 450 mg/day, with supportive long-term safety data from open-label extensions, and supplementary analyses on milnacipran's PGIC relationshi…

    DOI: 10.1016/j.jpain.2009.01.303

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question